Hinderling P H
Scand J Infect Dis Suppl. 1978(14):25-35.
Administration of an active drug to the intact human body leads to a "drug-body" interaction: the drug exerts its effect on the body, the body disposes of the drug. Administration of an antimicrobial drug to a human body infected with pathogenic bacteria leads to a "drug-bacteria" interaction in addition to "drug-body" and "bacteria-body" interactions. Of these complex interacting mechanisms only the disposition effect of the human body on antibacterial drugs and the effect of antimicrobial agents on bacteria have been quantified, analyzed, and are thus predictable. Postulates have been derived from the findings of these studies and have given the rationale for proper antimicrobial therapy under clinical conditions: antimicrobial actions are functions of the duration and concentration of the active antimicrobial principle at the physiological site of action. Optimal therapeutic efforts consider the need for individual treatment with respect to the choice and type of dosage regimen of the antimicrobial agent administered.
向完整的人体施用活性药物会导致“药物 - 机体”相互作用:药物对机体产生作用,机体对药物进行处置。向感染病原菌的人体施用抗菌药物除了会导致“药物 - 机体”和“细菌 - 机体”相互作用外,还会导致“药物 - 细菌”相互作用。在这些复杂的相互作用机制中,只有人体对抗菌药物的处置作用以及抗菌剂对细菌的作用得到了量化和分析,因此是可预测的。从这些研究结果中得出了一些假设,并为临床条件下的合理抗菌治疗提供了理论依据:抗菌作用是活性抗菌成分在生理作用部位的持续时间和浓度的函数。最佳治疗措施考虑了在选择所施用抗菌剂的剂型和剂量方案类型方面进行个体化治疗的必要性。